to the editor as a psychiatrist i find it disturbing to see how the pharmaceutical industry has ratcheted up the pressure to prescribe the newer more expensive atypical antipsychotic medications in preference to older drugs front page may 20 until recently psychiatrists have raised too few questions about the differences between the older and the newer drugs when used for acute psychosis psychotic depression bipolar disorder aggressive behavior schizophrenia and other problems practice patterns have been largely shaped by drug company sponsored research and by the opinions of experts who receive stipends from these companies psychiatrists need a more independent relationship with the drug industry both we and our patients would benefit david e ness md pittsburgh may 23 2003

